Exploring Massage Benefits for Arthritis of the Knee

Completed · Phase 2

Conditions studied: Osteoarthritis of the Knee

In brief

In 2004, we conducted a pilot randomized, wait list controlled, trial (RCT) of massage therapy for OA of the knee in 68 subjects. That study, supported by CDC grant SIP-14-00, revealed the potential efficacy of Swedish massage therapy in the treatment of OA of the knee, with benefits of increased function and decreased pain persisting at least eight weeks following treatment cessation. The results of that trial, the first RCT of massage for OA, were published in the Archives of Internal Medicine in 2006 (See reference in More Information section). This current project builds on the design and findings of the pilot trial to determine the optimal dose and treatment regimen and provide longer term follow up. This project is a dual-site, randomized, dose-ranging trial to compare four dose/regimens in order to identify the optimal protocol for clinical practice. The primary study hypothesis is that an eight (8) week course of Swedish massage therapy of one of the four proposed doses (by frequency and duration of massage treatment session) will be effective in reducing pain and improving function in patients with confirmed OA of the knee.

Key facts

Study ID

NCT00970008

Run by

University of Medicine and Dentistry of New Jersey

People needed

125

Starts

2009-09-01

Expected to finish

2011-08-01

Last updated by the study team

2015-05-05

Who can join

Age: 35 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 35 years of age or greater.
• Written confirmation of OA of the knee as provided by the participant's physician.
• Radiographically-established OA of the knee.
• Pre-randomization score of 40 to 90 on the Visual Analog Pain Scale (0-100 mm scale).
• Patients with bilateral knee involvement will have the more severely affected knee designated as the study knee.
• American College of Rheumatology defined OA of the knee:
• Knee pain
• Satisfaction of at least five of the following nine criteria:
• <!-- -->
• Age greater than 50 years
• Stiffness < 30 minutes
• Crepitus
• Bony tenderness
• Bony enlargement
• No palpable warmth
• ESR < 40 mm/hr
• Rheumatoid Factor (RF) < 1:40
• Exclusion Criteria: (no exclusion criterion may be present)
• Presence of rheumatoid arthritis, fibromyalgia, recurrent or active pseudo gout.
• Presence of cancer or other serious medical conditions.
• Signs or history of kidney or liver failure.
• Presence of asthma requiring the use of corticosteroid treatment.
• Use of oral corticosteroids within the past four weeks.
• Use of intra-articular knee depo-corticosteroids with the past three months.
• Use of intra-articular hyaluronate with the past six months.

Where it is running

• Yale-Griffin Prevention Research Center/Griffin Hospital — Derby, Connecticut, United States
• Siegler Center for Integrative Medicine - Saint Barnabas Ambulatory Care Center — Livingston, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.